The immunoassay of insulin in blood of infants born to diabetic mothers is complicated by the presence of anti-insulin antibodies.
Introduction
production of insulin in the newborn infants of diabetic mothers and to confirm and extend the work previously The development ofimmuno-chemical methods for the reported by BAIRD and FARQUHAR [1962] . Some of the assay of insulin following the work of YALOW and BER-problems encountered, which were due to interference SON [1960] has made readily available suitable micro-in the immuno-chemical assay procedures by techniques which are specific for the insulin molecule. endogenous maternal antibodies to insulin, are discThe present paper outlines a study to investigate the ussed.
T h e infants described were born a t the Simpson Memorial Maternity Pavilion to fourteen diabetic women of whom twelve had been treated with insulin u p to the timc of delivery (table I) . One other had received insulin over a four-year period but had had none in the eight years prior to this birth, having had dietary treatment and chlorpropamide. Another had been treated with diet alone. The mothers of the four control infants wcrc judged to be normal. These infants were born a t full-term and were of normal birth weight. The mothcrs had no family history ofdiabetes mellitus, and their prc\rious obstetric records were unremarkable. Each had had an avcrage of twelve urine tests from first reporting for antenatal care u p to the actual delivery, and none had glycosuria. Under these circumstances further glucosc tolerance testing was not undertaken.
T h e plasma insulin was studied only in the cord blood of some babies, but in others this was accompanied by an investigation of the plasma insulin response to the injection of glucosc. When this was to be done the baby was first given a placental transfusion in order to ensure a n adequate blood volume. The method of injecting glucose into and of taking blood samples from the umbilical vein was similar to that previously used (BAIRD and FARQUIIAR [1962] ) but the tip of the catheter was positioned a t less than 7.5 cm from the anterior abdominal wall in most cases when blood was freely obtained.
Glucose was injected a t exactly two hours after birth, and plasma insulin1 was determined before and so far as this was possible on seven occasions after the glucose had been given. T h e dose of glucose was again calculated as 0.5 g per kg body weight, and it was given quickly as a 20 % solution. All infants were handled as little as possible and were nursed comfortably a t a n environmental temperature of approximately 32" C.
Plasma insulin was measured by immuno-assay techniques. These methods use a specific antiserum for sampling mixtures of insulin and radioactive insulin --I The term 'insulin' here means immunologicallyreactive insulin under the conditions of the method used. under conditions where the proportion of antibodybound radioactivity is related to the non-radioactive insulin concentration.
The procedures used were based on those of YALOW and BERSON [1960] , in which the antibody-bound insulin and the free insulin were separated by paper chromatography using 0.072M barbitone buffer, p H 8.6 as solvent, and of HALES and RANDLE [1963] in which cellulose acetate filters were used to retain the bound insulin. This method is fully described in The Radiochemical Centre Data Sheet 5581 [1965] .
The '251-insulin was obtained from The Radiochcmical Centre, Amersham, Bucks, England, and had a specific activity of not less than 50 microcurics per microgram.
The anti-insulin serum and the insulin binding reagent, consisting of the antibody precipitate from the first stage of Mcthod C of HALES and RANDLE [1963] , were prepared at Thc \.Yellcome Research Laboratories. These antisera react under the conditions described with similar sensitivity to ox, human and pig insulin~. The final dilution of thc anti-insulin sera was 1/48,000.
The scnsitivity of thc assay systems was 0.4 microunits insulin, and the standard deviation over the concentration range 0.4 to 10 microunits insulin was 3 to 4 % of the mean.
The binding of 12"-insulin by plasma proteins was determined by the chromatographic separation used in the YALOW and BERSON [I9601 immuno-assay technique.
Results

a ) Recognition of Interferetzce in the Assay
'The insulin lcvels in the plasma of cord blood assayed by the HALES and RANDLE [I9631 method are shown in table I1 and are in general very much higher, with the exceptions described below, than expected from previous work using the rat diaphragm method of insulin assay (BAIRD and FARQUITAR [1962] ). T o test the validity of these findings insulin assay by the YALOW and BERSON [1960] technique was carried out in some cases but indicated negligible amounts of insulin present. This method differs essentially from that of HALES and RANDLE [I9631 only in the way by which insulin bound to the added antibody is separated from the unbound 'frcc' insulin.
Chromatographic separation as used in the YALOW and BERSON [I9601 method showed that considerable amounts of radioactive insulin migrated on filter-paper strips with the plasma proteins of infants of insulintreated diabetic mothers, even in the absence of added anti-insulin serum. Cases 309 and 310 behaved differently, the mother of the first never having had insulin while that of the second had had none in recent years (table 11).
6) Localisntion of the Interferet~ce
Thc electrophoretic separation of plasma proteins on cellulose acetate strips in 0.04 M barbitone buffer at p H 8.6 following the incubation a t 4OC at p H 7.4 of 0.2 ml of plasma with 250 micro-micrograms of '?"-insulin for four days indicated that where binding ~f'~"-insulin in plasma was high the radioactivity was found in the gammaglobulin and inter-betagamma zones. Where the binding was low the radioactivity was mainly in the alpha globulin zones (table  111) and probably represents denatured insulin. These findings are in keeping with those of PROUT el al. [1963] .
O n precipitation of the globulins by the addition of sodium sulphite to a final concentration of 22 per cent, 38 per cent of the radioactivity remained in the preeipitate after solution and reprecipitation in the case of thc infant of the diabetic mother treated with insulin, 18 per cent in the infant of the non-insulin treated diabetic mothcr, and 22 per cent in the infant of the non-diabetic mother. The precipitates redissolved in an 0.85 per cent solution of sodium chloride were subjected to zone elcctrophoresis on cellulose acetate a t p H 8.6. The fractions representing gamma and beta globulins were the only ones present in significant amounts.
From these findings it was concluded that insulin was bound to a protein or proteins present in the gamma and inter-beta-gamma fractions of plasma and that this protein was similar or identical to the antibody produced in diabetics receiving insulin therapeutically for a period of time.
c) Dilution of I~tterferer~rc
An attempt was made to overcome the effects of the endogenous antibody on the assay of insulin by dilution of the plasma to give final dilutions of between 1 in 3 and 1 in 30. Dilution beyond this was not considered practicable because of loss of scnsitivity in the assay method. Where reasonable agreement was achieved between the HALES and RANDLE method and that of YALOW and BERSON, dilution had reduced the effect of the endogenous antibody to negligible proportions. The cffcct could not be eliminated in other cases (table  IV) . As thc interference in the immuno-assay teehniques is due to a specific antibody and not to a nonspecific antagonist, the effect can at best be only minimized and not completely removed as the antibody retains a proportionate activity a t any dilution.
d ) Plastna Insulin Reslonse to Injected Glucose
It was thus possible to follow the changes in insulin levels aftcr the administration of intravenous glucose
The effect of endogenous antibody on insulin-assay in the newborn infants of diabetic mothers 1 13 to the infants of diabetic mothers. While these values do not necessarily represent the absolute amounts of insulin in the plasma, as the endogenous antibody had still some effect in most cases, it was possible to show that the infants of the diabetic mothers responded to an intravenous glucose load by sharp increments in insulin levels almost immcdiately (table 4) and that the insulin levels with one exception fell rapidly to values near the pre-glucose levels. I n those babies, 309 and 310, whose mothcrs had had no reccnt insulin therapy and whose plasma insulin binding capacity was correspondingly low, thc rise in plasma insulin lcvcl was clcar. Final plasma dilution 1 in 3 1 i n 1 5 1 i n 3 0 1 i n 1 5 1 i n 1 5 1 i n 1 5 1 i n 6 1 i n 6
Time nfier birth Maternal
---------- As cxcmplificd in table V, the changes in plasma insulin levrls following glucose could not be explained by changes in the binding of radioactivity by the cndogenous antibody. The presence of antibodies in the plasma of insulintreated diabetics has been recognized for some time (LERMAN [I9441 ; LOWELL [1944] ), and recently SPEL-LACY and GOETZ [ 19631 demonstrated that non-precipitating insulin-binding antibodies were found in newborn infants whose diabetic mothers had received insulin therapy. These antibodies were believed to originate in the mother. Plasma insulin determinations by immuno-assay procedures in insulin-treated adults are made difficult by the presence of endogenous insulin antibodies (YALOW and BERSON [1961] ). The presence ofantibody affects the assay in a way which is unique to immunoassays but the effect upon the apparent values for insulin depends upon which of the variations of the immuno-chemical methods is used. As the present work shows, the method which separates the insulin-antibody complex in the soluble form (YALOW and BERSON [1960] ) will give low values for insulin in the presence of endogenous antibody, while the method of HALES and RANDLE [1963] , and also that of MORGAN and LAZAROW [1963] , which separate the insulin-antibody complex in an insoluble form, gives high values for insulin in the presence of endogenous antibody. Possibly the interference by endogenous antibody could account for the high values found by immuno-assay trchniqucs in those infants of diabetic mothers studied by STIMMLER, BRAZIE and O'BRIEN 119641 as pointed out by KLINK and ESTRICH [1964] .
YALOW and RERSON [I9611 found that this problem could occasionally be overcome by making use of the great sensitivity of their immuno-assay procedure with human 1311-insulin and by diluting the plasma as much as fifty times. In the present study the apparent high values for plasma insulin could be rationalised by dilution of the plasma, though the sensitivity of the method limited the extent of dilution. The plasma of those infants whose mothers had had no or no recent insulin gave comparable results with diluted and undiluted specimens. I n most cascs the plasma antibodies were still capable of binding considerable amounts of ' 261-insulin even at the greatrst dilutions used, and in these cascs the guinea-pig anti-insulin serum added for the assay was not able effectively to reduce the amount of radioactivity which was bound to the plasma antibody. The importance of rstablishing the extent to which plasma gamma globulins will bind 12"-insulin before accepting values for plasma insulin obtained by immuno-assay seems clear. This is necessary evrn with diluted plasma.
Preliminary extraction of plasma with acid-alcohol has been used (GRODSKY and FORSHAM [1960] ) to allow the cletrrmination of insulin in plasma from adult diabetics with circulating non-precipitating insulin antibodies. The limitations imposed on the size of the samples which could be taken from newborn infants prevented this technique from being used effectively in the present study. This same consideration also applied to the method of separation of antibody-bound insulin from unbound 'free' insulin by gel filtration (MANIPOL and SPITZY [1962] ). Ultra-centrifugation has also been used for this separation (YALOW and BERSON [1961] ). An increase in the sensitivity of the method of assay together with greater dilution of plasma could offset the effects of the interference but would certainly not eliminate it in many cases.
Allowing that the effects of the endogenous antibody have not been entirely removed, the present study indicates that the infant of the diabetic mother responds to an intravenous glucose load by producing immediate and large increases in plasma insulin similar to those found previously (BAIRD and FARQUHAR [1962] ). Given that the insulin levels found cannot be explained by increased binding capacity following the glucose load, and that the maternal antibody to animal insulin seems to have low affinity for human insulin (YALOW and BERSON [1961] ), it does appear that the infant of the diabetic mother responds to a glucose load by release of insulin. This is also the experience of JORGENSEN, DECKERT, PEDERSEN and PEDERSEN [I9661 who, faced with the same problem of antibody inter-T h e effect of endogenous a n t i b o d y o n insulin-assay i n t h e n e w b o r n infants of diabetic mothers 115 ferrnce, found a sharp rise in insulin levrls after an intravenous glucose load. In contrast to the present study they gave the glucose at a variablr time after birth and chose to look for the insulin response five minutes aftcrward, whcrras the prrsent study suggests that thr prak may already havr bren passcd at this timr. T h r fasting insulin levels in thr two infants of non-insulin-trratcd diabetics in this series are low, while in the two described by JBRCENSEN et al. [1966] , they are high. T h e truth must bc drcided in a more extensivc study, but the present finding is at lrast consistcnt with that described by BAIRD and F A R Q~J I~A R [1962] . T h e rapid insulin rcsponse to glucosr in the babies of non-insulin-trrated mothrrs closely rcsrmbles the pattern in those of the insulin-treated group, and is uncomplicated by insulin antibody intrrfrrencr in thr mrthod of assay.
The prrsencc of antibody to exogenous insulin in the plasma of infants newly born to insulin-treated diabeticmothrrs makes difficult thr quantitation of the plasma insulin. Failurr to rccognisc this may causr errors both in measurement and in interpretation.
The cfrect ofmatcrnal antibody may be partly overcome by dilution, and in the prcsent study this mrthod and the investigation of babies born to two xnothcrs who had rcrc-ived little or no previous insulin treatment confirms that nrwborn infants of diabetic mothers respond vrry rapidly to an intravenous load of glurose by the release of insulin. Until the problrm of endogenous antibody interference with accurate quantitation of plasma insulin by immunochcmical mcthods is overcome, the measurement of such and of the insulin response to injected glucose may require to be confined to those babies whose mothers have not had insulin therapy.
